These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20605877)

  • 21. TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors.
    Edry E; Azulay-Debby H; Melamed D
    Int Immunol; 2008 Dec; 20(12):1575-85. PubMed ID: 18974086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging roles of TLR7 and TLR9 in murine SLE.
    Santiago-Raber ML; Baudino L; Izui S
    J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
    Wang D; Bhagat L; Yu D; Zhu FG; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Jan; 52(2):551-8. PubMed ID: 19102653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
    Azulay-Debby H; Edry E; Melamed D
    Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
    Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
    Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
    Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
    Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M; Lee LN; Evans GF; Zuckerman SH
    J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
    Kat I; Makdasi E; Fischel R; Eilat D
    Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire.
    Silver K; Ferry H; Crockford T; Cornall RJ
    Eur J Immunol; 2006 Jun; 36(6):1404-12. PubMed ID: 16703567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
    Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
    Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
    Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
    J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J; Weeratna R; Payette P; Jurk M; Schetter C; Laucht M; Wader T; Tluk S; Liu M; Davis HL; Krieg AM
    Eur J Immunol; 2004 Jan; 34(1):251-62. PubMed ID: 14971051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase.
    Séité JF; Guerrier T; Cornec D; Jamin C; Youinou P; Hillion S
    J Autoimmun; 2011 Nov; 37(3):190-7. PubMed ID: 21689906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology. Discriminating microbe from self suffers a double toll.
    Goodnow CC
    Science; 2006 Jun; 312(5780):1606-8. PubMed ID: 16778043
    [No Abstract]   [Full Text] [Related]  

  • 38. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D; Wang D; Zhu FG; Bhagat L; Dai M; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Aug; 52(16):5108-14. PubMed ID: 19650625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
    Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
    Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of nature and length of linker incorporated in agonists on toll-like receptor 9-mediated immune responses.
    Putta MR; Yu D; Bhagat L; Wang D; Zhu FG; Kandimalla ER
    J Med Chem; 2010 May; 53(9):3730-8. PubMed ID: 20361743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.